Recent Articles from StockStory

Shares of fuel cell technology Plug Power (NASDAQ:PLUG) jumped 22.1% in the afternoon session after the company announced a significant project milestone: the delivery of its first 10-megawatt (MW) electrolyzer module to Galp's Sines Refinery in Portugal. This delivery marks the initial step in what is set to become one of Europe's largest proton exchange membrane (PEM) hydrogen electrolyzer projects. The module is the first of a 10-electrolyzer array that will create a total capacity of 100 MW. Once completed, the project will be capable of producing up to 15,000 tons of renewable hydrogen annually. This green hydrogen will replace 20% of the grey hydrogen currently used by the refinery, significantly reducing its greenhouse gas emissions. The news boosted investor confidence, highlighting Plug Power's progress in deploying its technology at scale and strengthening its position in the European green energy market.

Shares of solar tracking systems manufacturer Array (NASDAQ:ARRY) jumped 10.3% in the afternoon session after the stock's positive momentum continued as analysts at both Baird and Deutsche Bank initiated coverage on the stock with favorable ratings. Baird assigned an "Outperform" rating, while Deutsche Bank started its coverage with a "Buy" rating, with both firms setting a price target of $11. In its analysis, Baird noted that the solar tracker maker stands to benefit from U.S. policy clarity and rising utility-scale solar demand. Deutsche Bank referred to Array Technologies as a "turnaround story," citing the management's focus on high-quality customers and a growing backlog of orders. The positive analyst sentiment coincided with a broader rally in the clean energy sector, supported by favorable developments such as changes in the EU's electricity market to better integrate solar energy.

Shares of customer platform provider HubSpot (NYSE:HUBS) fell 7.2% in the afternoon session after OpenAI announced internal software applications that could potentially compete with existing Software-as-a-Service (SaaS) offerings. The news sparked concerns across the sector, as OpenAI revealed internally developed tools for sales, inbound marketing, and customer support—core areas for HubSpot. According to TD Cowen analyst Derrick Wood, the announcement has "re-fueled the debate that SaaS is at risk of being displaced by DIY solutions on top of LLMs." The potential for OpenAI to enter the applications market with its own AI-native solutions triggered a broader sell-off among enterprise software stocks. Despite the negative sentiment, Wells Fargo initiated coverage on HubSpot with an "Overweight" rating and a price target of $685, signaling confidence in the company's long-term prospects.

Shares of go-to-market intelligence provider ZoomInfo (NASDAQ:GTM) fell 4.4% in the afternoon session after Wells Fargo initiated coverage on the software company with an 'Underweight' rating. The bank and analyst Ryan Macwilliams set a price target of $10.00 for the stock. This new coverage was part of a broader initiation by Wells Fargo on 18 small and mid-cap software stocks, with the bank highlighting artificial intelligence as a major turning point for the sector. While several other companies received 'Equal Weight' ratings, ZoomInfo was singled out with the negative 'Underweight' assessment, indicating that the bank is less optimistic about its future performance compared to its peers.

Shares of bitcoin development company Strategy (NASDAQ:MSTR) jumped 4.5% in the afternoon session after the U.S. Treasury Department and IRS indicated the company may avoid the 15% U.S. corporate alternative minimum tax on its substantial unrealized cryptocurrency gains. The interim rule clarifies that companies can exclude unrealized gains and losses on digital assets, such as Bitcoin, when calculating their tax liability. This development is particularly significant for Strategy, the world's largest corporate Bitcoin holder, as it has previously flagged the risk of a multi-billion-dollar tax bill on its more than $27 billion in unrealized profits. The favorable guidance removes this major financial uncertainty for the company. The stock's rise also occurred as the price of Bitcoin surged, lifting other cryptocurrency-linked equities.

Shares of clinical research company IQVIA (NYSE: IQV) jumped 6.3% in the afternoon session after the company, in partnership with GSK, announced a major update to its Vaccine Track data tool for tracking adult immunization activity in the U.S. The enhancement adds local-level data for 387 metro areas and expands the dataset to a full decade of information. This update is designed to help public health organizations and providers identify immunization gaps and improve their community outreach efforts. The collaboration with pharmaceutical giant GSK underscores IQVIA's role in providing critical health data analytics. This development occurs within a positive industry context, as the broader biologics contract research organization market, a key sector for IQVIA, is projected to experience strong growth due to increased outsourcing of R&D by large pharmaceutical firms.

Shares of industrial products company CSW (NASDAQ:CSW) jumped 4.2% in the afternoon session after the company announced agreed to acquire Motors & Armatures Parts (MARS) for $650 million in a cash deal. The acquisition, which is CSW's largest to date, includes a potential $20 million earn-out based on future revenue targets. MARS is a leading North American distributor of parts for heating, ventilation, air conditioning, and refrigeration (HVAC/R), which will significantly expand CSW's product portfolio in that market. Investors reacted positively as the deal is expected to be immediately accretive to CSW's earnings. The company projects the acquired business will achieve an EBITDA margin of over 30% within 12 months of the transaction's closing, signaling a strong potential for accelerated growth and increased shareholder value.

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 2.1% in the afternoon session after the company announced a specialty pharmacy partnership with Curant Health. Corcept has selected Curant Health's 'Curant Rare' division to provide personalized care and coordinated access to therapy for its patients. The partnership is designed to offer comprehensive support to patients and caregivers, helping them navigate the complexities of their treatment. This development comes as Corcept continues to rely on its sole-marketed drug, Korlym, for treating Cushing's syndrome. The company is also working to advance its lead pipeline candidate, relacorilant, for the same condition, aiming to broaden its patient base and reduce its dependence on a single product in the future.

Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after its subsidiary, Leica Biosystems, announced the launch of new artificial intelligence (AI)-powered digital pathology solutions. 

Shares of EV charging infrastructure provider Blink Charging (NASDAQ:BLNK) jumped 8.5% in the afternoon session after the company announced it has been awarded a contract by the City of Richmond to develop a network of electric vehicle (EV) charging stations. 

Shares of data center products and services company Vertiv (NYSE:VRT) jumped 6.8% in the afternoon session after Barclays raised its price target on the stock, citing strong demand for artificial intelligence (AI) infrastructure. 

Shares of health insurance company Humana (NYSE:HUM) fell 5.2% in the afternoon session after the company announced it will reduce the reach of its Medicare Advantage plans next year, citing rising costs. The health insurer will decrease its Medicare Advantage presence from 48 states to 46 and will cover 85% of U.S. counties, down from 89% this year. This decision comes as insurers face higher utilization of medical services and claim that government payments have not kept up with increasing costs. The pullback is not unique to Humana, as other major insurers are also retreating from less profitable markets. For instance, CVS Health's Aetna announced a similar reduction in its plan offerings. Despite the smaller footprint for its main Medicare Advantage plans, Humana did note that it expects to lower premiums for about 83% of its stand-alone prescription drug plans in the coming year.

Shares of semiconductor maker Penguin Solutions (NASDAQ:PENG) jumped 2.3% in the afternoon session after an analyst at Rosenblatt reiterated a "Buy" rating and significantly raised the price target on the stock. Rosenblatt analyst Kevin Cassidy increased the price target on Penguin Solutions to $36 from $27, representing a 33.33% jump in expected value. The firm anticipates the company will surpass consensus estimates and its own fiscal 2025 guidance. This optimism is reportedly driven by stronger-than-expected memory demand and pricing. Cassidy noted that Penguin Solutions, which is scheduled to report its fiscal fourth-quarter results on October 7, is likely to deliver a "modest beat" on expectations due to these favorable market conditions.

Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 5.2% in the afternoon session after the company submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for its drug candidate pivekimab sunirine. The company is developing the molecule as a potential treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and highly aggressive blood cancer, as well as acute myeloid leukemia (AML). Investor optimism was further bolstered by AbbVie's announcement of a $70 million expansion of its Bioresearch Center in Massachusetts to increase its U.S. biologics manufacturing and R&D capabilities. This move is part of a larger investment to strengthen domestic operations, potentially shielding the company from pharmaceutical tariffs. The positive news, which followed the stock reaching an all-time high on the previous day, appeared to outweigh a downgrade from HSBC to 'Hold' from 'Buy'.

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 7.2% in the afternoon session after the company announced a landmark agreement with the U.S. government aimed at lowering prescription drug prices for American patients. 

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.6% in the afternoon session after the stock's positive momentum continued as the White House revealed plans to launch a website for consumers to purchase drugs from manufacturers at a discount, providing clarity for the pharmaceutical industry on future pricing policies. The positive sentiment was bolstered by news that competitor Pfizer had already secured a deal to lower some of its U.S. drug prices. Following this, Eli Lilly confirmed it is in "active discussions with the administration to further expand patient access." This development has eased investor concerns about potential government-imposed price controls, which had created uncertainty for the sector. The prospect of reaching favorable agreements is now seen as an opportunity for major drugmakers, leading to a rally across the industry.

Shares of electronic signature company DocuSign (NASDAQ:DOCU) fell 4.2% in the afternoon session after the stock continued to decline as ChatGPT developer OpenAI unveiled a new competing product, DocuGPT. 

Shares of electronic trading platform Tradeweb Markets (NASDAQ:TW) fell 3.8% in the afternoon session after Morgan Stanley lowered its price target on the stock to $125 from $149. Despite the significant 16% reduction in the price target, the investment firm, led by analyst Michael Cyprys, maintained its "Equal-Weight" rating on the shares. The adjustment was part of a broader update of price targets for companies in the Brokers & Exchanges North America sector. The negative sentiment surrounding Tradeweb also coincided with wider market weakness, as U.S. stocks declined following the failure of lawmakers to reach a funding deal, which triggered a government shutdown and clouded the economic outlook for investors.

Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers. 

Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 9% in the afternoon session after the company secured a major manufacturing agreement with biotechnology firm Vaxcyte and announced a new AI-focused partnership. 

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the afternoon session after the company announced the launch of BioInsight, a new business unit designed to accelerate drug discovery using artificial intelligence. The new venture aims to help researchers and pharmaceutical companies analyze and interpret vast amounts of complex biological data, known as multiomic data. By combining its strengths in genetic sequencing, software, and AI, Illumina's BioInsight unit will provide solutions to identify new drug targets, understand biological pathways, and uncover disease mechanisms. This strategic move is intended to meet growing industry demand for data-driven insights, supporting the company's long-term growth by expanding its role in the life sciences and healthcare sectors.

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed at increasing drug production at its biologics facility in Juncos and is expected to create nearly 750 new jobs, including highly skilled manufacturing roles. According to CEO Robert A. Bradway, the expansion highlights Amgen's commitment to US biomanufacturing and strengthening its global supply chain. In other news, the company reached a settlement with Biocon Biologics. The agreement resolves pending patent litigation and allows Biocon to launch biosimilar versions of Amgen's drug, denosumab, in the U.S. starting October 1, 2025.

Shares of medical professional network Doximity (NYSE:DOCS) fell 3.2% in the afternoon session after Goldman Sachs downgraded the stock to Sell from a Neutral rating. The investment bank cited concerns over the company's high valuation and slowing growth, which it believes create an unfavorable risk/reward scenario for investors. Goldman Sachs set a price target of $64 for the stock.

Shares of devSecOps platform provider GitLab (NASDAQ:GTLB) fell 3.3% in the afternoon session after Wells Fargo initiated coverage on the stock with a neutral 'Equal Weight' rating. The bank set a price target of $50 per share. According to the firm, the cautious stance stems from a challenging near-term outlook as GitLab implements a new go-to-market sales strategy while facing tougher year-over-year pricing comparisons. Wells Fargo also cited investor uncertainty regarding GitLab's guidance for the upcoming year as a factor. While acknowledging the company's impressive profit margins and revenue growth, the analyst prefers to wait for a better entry point as new leadership establishes itself and the competitive landscape evolves.

Shares of electrical safety company Atkore (NYSE:ATKR) jumped 2.6% in the afternoon session after it extended gains from the previous day as it was reported that activist investor Irenic Capital Management has acquired a stake and is urging the company to pursue a sale. The positive momentum follows Tuesday's news, where the stock also rose after reports revealed Irenic Capital had built a 2.5% stake in the electrical manufacturing company. According to sources familiar with the matter, Irenic has privately engaged with Atkore's board, advocating that a sale to a private equity firm would be the best outcome for shareholders. This development comes as Atkore is already exploring its strategic options. The company had previously disclosed it is "evaluating a broad range of alternatives" and has reportedly enlisted Citigroup to assist with its strategic review process.

Shares of technology real estate company Opendoor (NASDAQ:OPEN) jumped 8.6% in the afternoon session after the company's new CEO, Carrie Wheeler, mandated that all employees must 'Default to AI' as part of a new company-wide policy. 

Shares of private corrections company GEO Group (NYSE:GEO) jumped 6.5% in the afternoon session after the company announced its subsidiary, BI Incorporated, was awarded a two-year contract by U.S. Immigration and Customs Enforcement (ICE). The agreement is for the continued provision of electronic monitoring, case management, and supervision services under the Intensive Supervision Appearance Program (ISAP). The contract begins with an initial one-year term, effective October 1, 2025, and includes an option for an additional year. This award confirms an ongoing relationship with a key government client, providing investors with increased confidence in the company's operational stability and future revenue from this program.

Shares of experiential tourism company Pursuit Attractions and Hospitality (NYSE:PRSU) fell 3% in the afternoon session after the company announced plans for a proposed issue of securities to raise capital. 

Shares of denim clothing company Levi's (NYSE:LEVI) jumped 3.2% in the afternoon session after BofA Securities raised its price target on the stock, citing strong demand for denim. The investment firm lifted its price target on Levi Strauss & Co. to $27 from $26, while maintaining its 'Buy' rating. Analysts at BofA pointed to the strength in the denim category and the brand's expanding global appeal as key reasons for their positive outlook. The firm also noted it expects positive earnings per share momentum for the company. This optimism aligns with broader trends in the apparel sector, where other major players have also recently reported strong growth, signaling healthy consumer demand.

Shares of intimatewear and beauty retailer Victoria’s Secret (NYSE:VSCO) jumped 6.1% in the afternoon session after an analyst at Telsey Advisory Group raised the company's price target to $29 from $24. While the firm, led by analyst Dana Telsey, maintained its "Market Perform" rating on the stock, the new price target represents a significant 20.8% increase. This adjustment signals a more optimistic outlook on the company's market performance and potential stock value. This positive revision provided a catalyst for the shares, as investors often see increased price targets as a sign of confidence from Wall Street in a company's future prospects, even without a formal rating change.

Shares of action camera company GoPro (NASDAQ:GPRO) jumped 4.3% in the afternoon session after the company announced a strategic shift, forgoing its traditional annual flagship camera update to unveil a trio of new products. For the first time in over a decade, GoPro is introducing a new lineup aimed at broadening its reach with creators. The new products include the GoPro MAX2, the GoPro LIT HERO, and the Fluid Pro AI gimbal, which collectively focus on versatility and user empowerment.

Shares of online real estate marketplace Zillow (NASDAQ:ZG) fell 4% in the afternoon session after the company was sued by the U.S. Federal Trade Commission (FTC) and a coalition of states over an alleged illegal scheme to eliminate competition in the online rental listings market. 

Shares of sporting goods retailer Academy Sports & Outdoor (NASDAQ:ASO) jumped 4.2% in the afternoon session after Barclays initiated coverage on the stock with a neutral 'Equal-Weight' rating. The bank set a price target of $51 for the sporting goods retailer. In its report, Barclays highlighted several positive factors, including a significant regional-to-national expansion opportunity with plans for about 160 new stores over the next four years. The firm also pointed to Academy's strong private label portfolio, which accounts for 23% of total sales, and favorable long-term trends in the sporting goods industry. However, the neutral rating also reflects certain risks, such as inventory growing faster than sales, challenges in elevating its footwear brand mix, and significant national competition, which contributed to a decline in the share price during the previous session. Today’s upward move suggests investors are focusing on the long-term growth potential outlined in the report.

Shares of athletic apparel brand Nike (NYSE:NKE) jumped 4.9% in the afternoon session after the company posted third-quarter results that surpassed Wall Street's expectations for both revenue and profit. The athletic apparel giant reported revenue of $11.72 billion, a modest 1.1% increase year-on-year, but this was enough to comfortably beat analyst estimates of $11 billion. Similarly, its GAAP earnings per share of $0.49 was significantly ahead of the $0.27 consensus forecast. Despite the strong beat against expectations, the results showed some underlying weakness. The company's earnings per share declined from $0.70 in the same quarter last year, and its operating margin contracted to 7.7% from 10.4%, indicating that expenses grew faster than revenue.

Shares of online grocery delivery platform Instacart (NASDAQ:CART) jumped 2.1% in the afternoon session after Cantor Fitzgerald reiterated its Overweight rating on the stock with a $63 price target, citing the company's strategic value. The investment firm highlighted that an acquisition by a company like Uber would make "plenty of sense strategically" and that Instacart's current valuation might also attract private equity investors. The note pointed to Instacart's dominant position in the U.S. grocery delivery market, with over 65% market share, and its "best-in-class tech." Cantor Fitzgerald also underscored the company's strong financial health, including impressive gross profit margins of nearly 75%, double-digit revenue growth, and a strong balance sheet with minimal debt, which supports the positive investment thesis.

Shares of earth imaging satellite company Planet Labs (NYSE:PL) jumped 6.5% in the afternoon session after the company announced it had shipped new satellites for an upcoming SpaceX launch and revealed plans to expand its manufacturing capabilities in Europe. 

Shares of streaming TV platform Roku (NASDAQ: ROKU) jumped 3.6% in the afternoon session after the company announced the U.S. launch of a new Philips Roku TV featuring Ambilight technology, alongside positive commentary from a Wall Street analyst. The new line of TVs, available for the first time in the U.S. with the Roku operating system, incorporates Philips' exclusive Ambilight feature. This technology uses intelligent LEDs built into the back of the TV to project colors onto the wall that match the on-screen action in real-time, creating a more immersive viewing experience. The televisions will be sold at Sam's Club locations across the United States. Adding to the positive sentiment, Needham analyst Laura Martin reiterated a 'Buy' rating on Roku's stock, maintaining a $110 price target. Martin's confidence is based on the company's ability to meet viewer demands for more personalized content and advertising experiences.

Shares of aerospace and defense company AeroVironment (NASDAQ:AVAV) jumped 8% in the afternoon session after the company was selected for a $499 million U.S. Air Force contract and announced enhancements for its Puma LE unmanned aircraft system. 

Shares of data streaming platform provider Confluent (NASDAQ:CFLT) fell 0.1% in the afternoon session after the company announced a new multi-year partnership with the Visa Cash App Racing Bulls (VCARB) Formula 1 team. 

Shares of buy now, pay later company Affirm (NASDAQ:AFRM) jumped 3.5% in the afternoon session after the company announced a partnership with Ace Hardware to provide 'buy now, pay later' options at participating stores across the U.S. 

Shares of marketing technology company Zeta Global (NYSE:ZETA) jumped 2.4% in the afternoon session after the company announced it agreed to acquire Marigold's enterprise software business for up to $325 million, a move that drew positive reactions from analysts. This acquisition was expected to add new capabilities to Zeta's AI-powered platform, expand its customer base, and extend its reach into international markets. Following the announcement, DA Davidson reiterated its 'Buy' rating on the stock. In a similar show of confidence, an analyst at Needham maintained a 'Buy' rating and increased the price target for Zeta Global's shares to $25.00 from a previous $20.00. The positive analyst sentiment stemmed from the deal's potential to improve Zeta's financial profile and growth prospects.

Shares of aerospace and defense company Mercury Systems (NASDAQ:MRCY) jumped 3.2% in the afternoon session after RBC Capital upgraded its rating on the company to Outperform from Sector Perform and raised its price target to $90. 

Shares of electrical construction and infrastructure services provider MYR Group (NASDAQ:MYRG) fell 2.5% in the afternoon session after Keybanc downgraded the stock from "Overweight" to "Sector Weight.". The investment bank noted that the electrical contractor's shares had approached its price target, suggesting the stock was now considered fairly valued. This move followed a remarkable run for the stock, which had gained over 102% in the previous year. Despite the rating change, Keybanc acknowledged the company's significant progress, highlighting that MYR Group had successfully overcome project execution challenges from about a year ago. The firm expressed a positive view of the company's operational improvements but determined the current share price adequately reflected its business performance and outlook.

Shares of fintech mortgage provider Rocket Companies (NYSE:RKT) jumped 1.8% in the afternoon session after the company announced it completed its $14.2 billion acquisition of Mr. Cooper Group, uniting the country's largest home loan originator with the largest mortgage servicer. 

Shares of equipment rental company Herc Holdings (NYSE:HRI) jumped 4.6% in the afternoon session after Baird upgraded the stock to 'Outperform' from 'Neutral' and raised its price target. The research firm lifted its price view on Herc to $160 from $137. This decision was based on seeing signs that the equipment rental industry was stabilizing, a trend expected to last into 2026. The analyst, Mircea Dobre, also pointed out that Herc's efforts to manage costs and its fleet after the H&E acquisition were improving the company's prospects. These factors were expected to help the company gradually reduce its debt, which could increase the value of its stock for investors.

Shares of blockchain infrastructure company Coinbase (NASDAQ:COIN) jumped 3.3% in the afternoon session after investment firm BTIG initiated coverage on the stock with a 'Buy' rating and a $410 price target. The analyst firm pointed to what it called 'underappreciated' growth areas, such as the company's derivatives business and the Base App. The positive news did not stop there, as Coinbase also surpassed $1 billion in bitcoin-backed onchain loans, showing significant growth for the service. Further bolstering investor confidence, new guidance from the SEC's staff allowed state-chartered trust companies, including Coinbase, to act as qualified custodians for crypto assets for investment advisers, clearing up regulatory uncertainty.

Shares of online community and discussion platform Reddit (NYSE:RDDT) fell 9.9% in the afternoon session after reports surfaced that OpenAI's ChatGPT was not using the social media platform's data as much as investors had anticipated. Concerns gained traction on the social media platform X, where multiple posts cited data from PromptWatch and Similarweb, suggesting ChatGPT was not heavily drawing on Reddit's content. The market reacted to fears that the company's data licensing partnership was less valuable than previously thought.

Shares of business development company Sixth Street Specialty Lending (NYSE:TSLX) fell 2.4% in the afternoon session after JP Morgan downgraded its rating on the company's stock from Overweight to Neutral. The firm, led by analyst Melissa Wedel, also set a new price target of $24.00 for the shares. An analyst downgrade from a rating like "Overweight" to "Neutral" typically signals a reduced expectation for the stock's performance. It suggests that the analyst no longer believed the stock would outperform the broader market or its sector in the near term. This change in outlook prompted some investors to sell their shares.

Shares of digital banking platform Dave (NASDAQ:DAVE) jumped 1% in the afternoon session after Benchmark reiterated its Buy rating and a $320 price target on the company's stock, while other analysts also raised their price targets. The positive analyst actions followed Dave's second-quarter 2025 results, which were reported to have exceeded expectations. Following the strong earnings, Freedom Capital Markets lifted its price target on the stock to $280, while Citizens JMP increased its target to $300. Benchmark's affirmation of its positive view came despite market concerns about potential credit issues, signaling confidence from the firm in the company's financial health and prospects.

Shares of aviation and defense services provider AAR CORP (NYSE:AIR) fell 6.8% in the afternoon session after the company announced the pricing of a public offering of 3 million shares of its common stock. The shares were priced at $83.00 each, which represented a 7.4% discount to the stock's last sale price. Such offerings can often lead to a drop in a company's stock price because they increase the total number of shares, which can dilute the value for existing stockholders. AAR expected to receive net proceeds of about $239 million from the sale. The company stated it planned to use the funds to repay outstanding debt and for general corporate purposes, which could include funding future acquisitions.

Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 5.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to its experimental antibody, BMS-986446, for the treatment of early Alzheimer's disease. This special status was intended to help speed up the development and review of drugs that treat serious conditions where there is an unmet medical need. The drug candidate, which was in a mid-stage trial, aimed to slow or delay the progression of Alzheimer's. Adding to the positive news, Bristol Myers Squibb also announced it had joined a consortium with other pharmaceutical companies, including Takeda and Astex, to use artificial intelligence to improve the drug discovery process.

Shares of exercise equipment company Peloton (NASDAQ:PTON) fell 8.7% in the afternoon session after the company announced a major product overhaul focused on artificial intelligence and higher prices, which failed to impress investors. Peloton unveiled a sweeping revamp of its portfolio, introducing an AI and computer vision system called Peloton IQ for personalized guidance. The relaunch also included new products and significant price increases across its equipment and monthly membership fees. For instance, the Bike+ price went up by $200, the base treadmill model increased by $300, and the Tread+ saw a $700 price hike. The monthly membership cost also rose by $5. While the stock saw a brief climb in pre-market trading following the news, the gains reversed sharply after the market opened, indicating that investors were ultimately unimpressed with the company's new strategy.

Shares of cloud communications provider RingCentral (NYSE:RNG) jumped 0.5% in the afternoon session after Wells Fargo started coverage of the stock with an 'Equal Weight' rating and a $32.00 price target. The firm cited a "balanced setup" for the communications company. Analysts noted RingCentral could benefit from reduced competition as businesses continued to replace older phone systems. Wells Fargo also highlighted that the company's "low multiple helps the story" as it works on migrations and potential artificial intelligence features for existing customers. Despite these positive points, the bank expressed caution about RingCentral's heavy focus on voice products, which could limit growth without a better economy. While the firm's valuation was viewed as low compared to its peers, Wells Fargo stated it was "awaiting clearer signs of momentum before becoming more constructive.".

Shares of packaged foods company Conagra Brands (NYSE:CAG) jumped 4% in the afternoon session after the company reported third-quarter revenue that topped Wall Street estimates, while earnings were in line with expectations. For the third quarter of calendar year 2025, Conagra's revenue fell 5.8% year-over-year to $2.63 billion, but this figure beat analysts' forecasts of $2.61 billion. The result came amid a challenging environment, as sales volumes fell 1.2%. The company's GAAP earnings per share of $0.34 matched consensus estimates but represented a significant drop from $0.97 in the same quarter last year. Despite the mixed results, investors reacted positively to the revenue and organic growth beats, suggesting relief that the performance was better than feared given the difficult consumer backdrop.

Shares of database platform company MongoDB (NASDAQ:MDB) jumped 2.4% in the afternoon session after Wells Fargo initiated coverage on the company with an "Overweight" rating and a $430 price target. The bank's analyst highlighted MongoDB's key position in the expanding artificial intelligence (AI) sector and its progress in agentic coding, a method where AI agents handle coding tasks on their own. The positive view was supported by the growing use of MongoDB's database architecture by companies developing AI products. This initiation followed other positive analyst actions and came after MongoDB recently launched its AI-powered Application Modernization Platform (AMP). The platform was designed to help businesses update their old applications more quickly, which reinforced the company's focus on AI-driven solutions.

Shares of online marketplace Etsy (NASDAQ:ETSY) jumped 6.3% in the afternoon session after investors continued to show optimism after the company announced a partnership with OpenAI to enable purchases directly through ChatGPT. The stock extended gains from previous trading sessions after the news first broke, sending shares to a 52-week high. The collaboration introduced an “Instant Checkout” feature, which allowed U.S. ChatGPT users to purchase products directly from U.S. Etsy sellers within the chatbot interface. This development was viewed as a way to boost sales for the online marketplace, which had previously reported falling gross merchandise sales. Following the announcement, analysts at BTIG raised their price target for Etsy's stock to $81 from $72. The firm estimated the partnership could generate about $100 million in gross merchandise value for Etsy.

Shares of residential solar energy company Sunrun (NASDAQ:RUN) jumped 8.4% in the afternoon session after Jefferies upgraded the stock from "Hold" to "Buy" and significantly raised its price target. Analyst Julien Dumoulin-Smith adjusted the price target to $21 from a previous $11, a substantial increase of over 90%. This move from the investment firm reflected a much more positive outlook for the company. Upgrades of this nature often signal to the market that an analyst sees improving business conditions for the company, which can attract investor interest and boost share prices.

Shares of freight transportation and logistics provider Saia (NASDAQ:SAIA) fell 3.9% in the afternoon session after Evercore ISI Group lowered its price target on the stock, though it maintained its "Outperform" rating. Analyst Jonathan Chappell cut the price target to $328 from $345, marking a nearly 5% reduction. This decision followed a period of weaker performance for the less-than-truckload transportation company. Saia had previously reported underwhelming sales. The company also faced challenges with profitability in some of its recently acquired markets, which did not perform as well as its legacy business. Furthermore, management had expressed concern about macroeconomic uncertainty affecting future shipping volumes.

Shares of customer engagement platform Twilio (NYSE:TWLO) jumped 1.4% in the afternoon session after Wells Fargo initiated coverage on the stock with an "Overweight" rating and a $130 price target. The bank's positive view stemmed from several key points. The firm cited the company's low risk of disruption from artificial intelligence and saw benefits from its role in providing infrastructure for voice AI. Additionally, analysts pointed to growth potential from the ongoing buildout of Rich Communication Services (RCS), an advanced messaging standard. The company's capacity for strong free cash flow generation was also noted as a significant financial strength.

Shares of solar energy systems company Shoals (NASDAQ:SHLS) jumped 5.1% in the afternoon session after UBS raised its price target on the stock to $9 from $7 and maintained its Buy rating. The firm pointed to Shoals' strong position to benefit from the growing demand for electricity and battery storage tied to data center expansion. In line with this outlook, UBS also increased its adjusted EBITDA estimates for 2025 through 2027. The higher forecasts were driven by expected revenue growth from Shoals' data center products and improved efficiency within its sales operations. The positive sentiment from UBS was consistent with that of other analysts, as eight had also revised their earnings estimates upward for the upcoming period.

Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 6.6% in the afternoon session after HSBC initiated coverage on the stock with a 'Buy' rating and a $150 price target. 

Shares of cloud monitoring platform Datadog (NASDAQ:DDOG) jumped 5.5% in the afternoon session after Wells Fargo initiated coverage of the company with an "Overweight" rating and a $190 price target. 

Shares of online used car dealer Carvana (NYSE: CVNA) jumped 1.7% in the afternoon session after Jefferies upgraded the stock to 'Buy' from 'Hold' and raised its price target. The analyst also increased the price target on the shares to $475 from $385. The upgrade was based on signs that Carvana could gain a larger share of the used-car market more quickly as shoppers shifted to online purchasing. Jefferies noted the company was well-positioned to lead in digital auto sales, helped by increased production capacity and faster delivery speeds. The firm's analysis, which included consumer surveys, also pointed to potential cost savings, expecting fixed costs per vehicle to fall over time, which would boost earnings.

Check out the companies making headlines yesterday:

Packaged foods company Conagra Brands (NYSE:CAG) announced better-than-expected revenue in Q3 CY2025, but sales fell by 5.8% year on year to $2.63 billion. Its GAAP profit of $0.34 per share was in line with analysts’ consensus estimates.

Intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) fell short of the market’s revenue expectations in Q3 CY2025, but sales rose 17.1% year on year to $1.21 billion. Its non-GAAP profit of $5.20 per share was 7.5% above analysts’ consensus estimates.

Egg company Cal-Maine Foods (NASDAQ:CALM) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 17.4% year on year to $922.6 million. Its GAAP profit of $4.12 per share was 19.2% below analysts’ consensus estimates.

Human capital management company Paychex (NASDAQ:PAYX) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 16.8% year on year to $1.54 billion. Its non-GAAP profit of $1.22 per share was 1.4% above analysts’ consensus estimates.

KB Home’s third quarter results were marked by a decline in sales but stronger-than-expected profitability, as management emphasized operational execution and cost control. The company noted steady demand across its communities and highlighted further reductions in build times, which enabled slightly higher deliveries than anticipated. CEO Jeffrey Mezger attributed the quarter’s results to improvements in construction efficiency and disciplined pricing, stating, “We produced total revenues of over $1.6 billion and diluted earnings per share of $1.61,” while also referencing the ongoing transition toward a higher mix of built-to-order homes.

Cintas’ first quarter results were shaped by robust demand across its route-based businesses and continued investment in operational efficiency. Management pointed to strong organic growth in Uniform Rental and Facility Services, First Aid and Safety Services, and Fire Protection Services, highlighting process improvements and successful customer conversions from do-it-yourselfers to Cintas’ programs. CEO Todd Schneider noted, “Our value proposition continues to resonate with customers in many different verticals, even in uncertain macroeconomic environments.” Segment-level margin improvements were attributed to strategic sourcing and technology initiatives.

Stitch Fix’s second quarter results drew a negative market reaction, with shares falling sharply after the report. Management attributed quarterly performance to continued progress in its transformation strategy, highlighting improvements in client experience and assortment, particularly the strength in its men’s business and expansion into non-apparel categories. CEO Matt Baer emphasized that both women’s and men’s lines saw accelerated revenue growth, driven by higher average order values and the addition of recognized brands. The company also noted that improvements in retention and client engagement led to year-over-year growth in revenue per active client for the sixth consecutive quarter, but active client numbers continued to decline.

Potato products company Lamb Weston (NYSE:LW) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $1.66 billion. On the other hand, the company’s full-year revenue guidance of $6.45 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.74 per share was 38.7% above analysts’ consensus estimates.

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. Their momentum is also rising as lower interest rates have incentivized higher capital spending. As a result, the industry has posted a 28.1% gain over the past six months, beating the S&P 500 by 9.3 percentage points.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.